Stefan K.F. Schwabe is Executive Vice President & CMO of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 2,772 shares of SUPN, which is worth approximately $89,064. The most recent transaction as insider was on Dec 21, 2020, when has been sold 46,347 shares (Common Stock) at a price of $22.1 per share, resulting in proceeds of $1,024,269. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.77K
0% 3M change
0% 12M change
Total Value Held $89,064

Stefan K.F. Schwabe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 21 2020
SELL
Open market or private sale
$1,024,269 $22.1 p/Share
46,347 Reduced 94.36%
2,772 Common Stock
Dec 21 2020
BUY
Exercise of conversion of derivative security
$601,584 $12.98 p/Share
46,347 Added 48.55%
49,119 Common Stock
Dec 14 2020
SELL
Open market or private sale
$1,176,610 $21.93 p/Share
53,653 Reduced 95.09%
2,772 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$593,402 $11.06 p/Share
53,653 Added 48.74%
56,425 Common Stock
SKS

Stefan K.F. Schwabe

Executive Vice President & CMO
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Track Activities on SUPN